002 Rapid improvement in reperfusion strategy in europe: temporal trends in performance measures for reperfusion therapy in ST elevation myocardial infarction  by Schiele, Francois et al.
© Elsevier Masson SAS. All rights reserved.
 
 
 
Archives of Cardiovascular Diseases Supplements (2011) 3, 1-25 1
 
TOPIC 01 – Coronary heart disease
001
 
Thromboaspiration before primary PCI in STEMI patients reduces
infarct size, but not microvascular obstruction : a magnetic resonance
imaging study
Nicolas Meneveau, Vincent Descotes-Genon, Romain Chopard, Joanna
Dutheil, Marie France Séronde, Florent Briand, Francois Schiele
CHU Besançon, Cardiologie, Besançon, France
Background:
 
 Thromboaspiration (TA) during primary percutaneous inter-
vention (PCI) is effective in opening infarct related artery (IRA) in
patients(pts) with ST elevation acute myocardial infarction (STEMI), leading
to better reperfusion and outcome. Microvascular obstruction (MVO) after
successful IRA revascularization is associated with greater myocardial
damage, left ventricular (LV) impairment and higher mortality. We evaluated
relationships between (i) TA and MVO 5 days after STEMI; (ii) TA and inf-
arct size at 5 days and 6 months; (iii) TA and LV remodelling at 6 months.
 
Methods:
 
 51 pts aged <75, with first STEMI and totally occluded IRA,
referred for primary PCI within 12 hours of onset of symptoms were enrolled.
All pts underwent TA before stenting. Pts were categorized according to positive
or negative TA. MVO, infarct size and remodelling were assessed by contrast-
enhanced cardiac magnetic resonance imaging (MRI) at 3T performed 5 days
and 6 months after STEMI. Infarct size was measured by assessing global myo-
cardial extent of hyperenhancement on delayed contrast-enhanced MRI. MVO
was defined as subendocardial areas of hypoenhanced signal surrounded by
hyperenhanced myocardial tissue and expressed as % of total myocardium.
 
Results: S
 
ee table.
 
Conclusion:
 
 Positive TA during primary PCI was associated with infarct
size reduction at 5 days and 6 months follow-up in STEMI pts with TIMI 0
flow IRA. Although this phenomenon led to positive LV remodelling, it was
not associated with a reduction in MVO. 
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Background:
 
 Rate and type of reperfusion, and delay to reperfusion are
related to mortality and used as performance measures (PM) in ST elevation
myocardial infarction (STEMI). Improvements in PM contribute to reduced
mortality. Litte information exists about the improvement of PM in clinical
practice in Europe. 
 
Methods:
 
 Euro Heart Survey ACS-III dataset. We selected patients(pts)
with STEMI eligible for reperfusion. Pts were divided into 4 periods of 6
months, by date of admission. Rate and type of reperfusion, plus door-to-
needle and -artery times were compared between periods. Timely reperfusion
was defined as a door-to needle time<30 minutes (min) or a door to artery time
<90 min. Independent predictors of timely reperfusion were determined by
logistic regression.
 
Results:
 
 7655 had STEMI and were eligible for reperfusion. Overall rep-
erfusion rate increased from 79.2 to 82.3% from period 1 to 4, with primary
percutaneous coronary intervention (P-PCI) in 69.9% and thrombolytic
therapy (TT) in 20.8%. There was a significant decrease in use of TT (25.4 to
17.3%) & an increase in P-PCI (70.4 to 79.3%) (p<0.001 for trend). Door-to-
needle and -artery times decreased significantly, from 20 to 11 min (p=0.01)
and from 60 to 45 min (p<0.0001) respectively. The number of pts reperfused
in a timely manner increased from 66.7 to 77.6% (p<0.0001). Independent pre-
dictors of timely reperfusion were: Killip class >2, increased systolic blood
pressure on admission, female sex, admission to high volume center and
admission period. In-hospital mortality decreased from 8.1% to 6.6%,
p=0.047. 
 
Conclusions:
 
 In Europe, from 2006 to 2008, PM for reperfusion in STEMI
improved significantly, particularly reperfusion rate, with more use of PCI.
The rate of patients reperfused in a timely manner also increased, through a
significant reduction in door to needle and door to artery times. Associated
with these improvements, we observed a significant decrease of hospital mor-
tality from 8.1% to 6.6%.
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Radial approach and bleeding risk in acute coronary syndromes
without ST elevation-comparison study between fondaparinus vs.
enoxaparin
Priscille Kamtchueng, Romain Gallet, Jean-Luc Dubois-Randé, Emma-
nuel Teiger, Pascal Lim
CHU Henri Mondor, Fédération de cardiologie, Créteil, France
Background:
 
 Fondaparinux compared to enoxaparin has been showed to
reduce the bleeding risk in acute coronary syndromes (ACS). However the
bleeding risk has never been compared when radial approach is used for per-
cutaneous coronary interventional (PCI). 
 
Method:
 
 We investigated 371 consecutive patients (67±13 years, 74%
male) admitted for ACS without ST elevation. All patients received a loading
dose of clopidogrel (600mg) and aspirin (250mg to 500mg). PCI was per-
formed through radial artery approach with IV heparin (3000UI) delivered
directly in radial artery. The choice between low molecular heparin (fonda-
parinux or enoxaparin) was let free to physician appreciation. Bleeding com-
plication was defined by the need of red cell transfusion of 2 units and in
hospital major cardiac events (MACE) by death, stroke and recurrent myocar-
dial infarction. 
 
Results:
 
 On the whole, 120 (32%) patients were treated by enoxaparin and
251 (68%) by fondaparinux. Patients treated by enoxaparin were older (71±13
years vs. 66±13 years, p=0.02) and at higher risk of bleeding complications
with greater plasmatic creatinin (114±77 vs. 94±57, p=0.005) and haemo-
globin level (12±2g/dL vs. 13±2g/dL, p<0.0001). However, bleeding compli-
cations occurring in only 6 (1.7%) patients did not differ between patients
treated by enoxaparin vs. fondaparinux (1.6% vs. 1.6%, p=0.9). Similarly, in
hospital MACE (3%, n=11) was similar in the two groups (3.3% vs. 2.8%,
p=0.8). 
 
Conclusion:
 
 Radial approach in ACS is associated with a low rate of
bleeding risk and is not affected by the choice of low molecular heparin. These
results demonstrate that both enoxaparin and fondaparinus may be used safely
when radial approach is performed in ACS. 
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 Negative TA
(N=34)
Positive TA
(N=17)
p
 
TIMI III flow post PCI (%) 91 % (31/34) 94% (16/17) 0.86
MVO at 5 days (%) 7.1 ± 5.7 6.8 ± 4.9 0.85
Infarct size at 5 days (%) 20.6 ± 8.1 9.9 ± 7.2 <10-5
Infarct size at 6 months (%) 16.4 ± 9.9 7.2 ± 8.1 .0007
LVSVI at 6 months (ml/m
 
2
 
) 27.5 ± 9.3 36.4 ± 12.2 0.01
 
LVSVI
 
 = 
 
left ventricular stroke volume index
